Evaluation of Dental Anxiety Levels on Oral and Dental Health Quality of Life in Patients with Hashimoto Thyroiditis

Year 2024, Volume: 4 Issue: 2, 52 - 58, 30.08.2024

Ayşenur Güngör Borsöken , Derya Gursel Surmelioglu , Songül Özdögen

https://doi.org/10.61139/ijdor.1535674

Abstract

Aim: This study aimed to evaluate the effect of anxiety level, dental fear, anxiety on oral health quality of life oral, and dental health in Hashimoto's thyroiditis patients.
Materials and Methods: Ninety adult individuals were included from Gaziantep University Faculty of Dentistry. All participants were asked about demographic parameters (age, gender), socio-economic status (education, marital status), and oral hygiene habits. The OHIP-14 and OHRQoL-UK questionnaires were used to asses the effect of individuals' oral health on their quality of life. Dental anxiety levels were evaluation with the Modified Dental Anxiety Scale (MDAS). Statistical analysis was performed using IBM SPSS Statistics 22.0.
Result: There were no significant differences for Sociodemographic data, dental habits, age, marital status, educational status, smoking, frequency of brushing tooth, frequency of visiting the dental clinic in OHIP-14, OHRQoL, and MDAS survey scores (p > 0.005). However, there was a statistically moderate positive correlation between the total OHIP-14 scores and the MDAS scores (r = 0.309; p < 0.003). Additionally, a moderate negative correlation was showed between the total OHRQoL and the MDAS scale (r = 0.307; p < 0.003).
Conclusion: In conclusion, this study showed that patients' quality of life regarding oral and dental health was low, regardless of individual factors. It was found that dental anxiety was lower in patients with HT, and a significant correlation betwen the quality of life and anxiety level was observed.

Keywords

OHIP-14, Hashimoto, MDAS, OHRQoL-UK

Ethical Statement

The study was initiated after obtaining written and verbal consent from the patients, prepared in accordance with the Helsinki Declaration and approved by the XXX University Non-Interventional Clinical Research Ethics Committee (Ethics Committee Approval date - No: 2020/281).

Supporting Institution

No technical or financial support was received from any institution or person in our study.

Thanks

There is no personal or financial conflict of interest between the authors.

References

• 1. Liontiris MI, Mazokopakis EEJHJNM. A concise review of Hashimoto thyroiditis (HT) and the importance of iodine, selenium, vitamin D and gluten on the autoimmunity and dietary management of HT patients. Points that need more investigation. 2017;20(1):51-6.
• 2. Nalbant A, Aydın A, İlçe HT, Cinemre HJOTJoHS. Haşhimoto Tiroiditli Olguların Klinik ve Laboratuvar Bulgularının Değerlendirilmesi. 2016;1(3):8-20.
• 3. Akarslan Zz, Erten H. Diş hekimliği korkusu ve kaygısı. Hacettepe Dişhekimliği Fakültesi Derg( Clinical Dentistry and Research). 2009;33(1):62-8.
• 4. Öcek Z, Karababa A, Türk M, Çiçeklioğlu M, Kandemir Ş. Ege Üniversitesi Diş Hekimliği Fakültesi'ne Başvuran Hastalarda Dental Anksiyete Etiyolojisinin Değerlendirilmesi. EÜ Diş Hek Fak Derg. 2001;22(121):9.
• 5. Freeman R. Barriers to accessing and accepting dental care. British Dental Journal. 1999;187(2):81-4.
• 6. Dikmen B, Saral I, Ucuncu MK, Yildiz E, Yildiz SOJBDS. The relationship between prevalence of dental anxiety and dental caries: cross-sectional study. 2022;25(1).
• 7. Klingberg G, Broberg AGJIjopd. Dental fear/anxiety and dental behaviour management problems in children and adolescents: a review of prevalence and concomitant psychological factors. 2007;17(6):391-406.
• 8. Berggren U, Meynert GJJotADA. Dental fear and avoidance: causes, symptoms, and consequences. 1984;109(2):247-51.
• 9. Bocchetta A, Tamburini G, Cavolina P, Serra A, Loviselli A, Piga MJCP, et al. Affective psychosis, Hashimoto's thyroiditis, and brain perfusion abnormalities: case report. 2007;3:1-5.
• 10. Kleinknecht RA, Klepac RK, Alexander LDJTJotADA. Origins and characteristics of fear of dentistry. 1973;86(4):842-8.
• 11. Tunc EP, Firat D, Onur OD, Sar VJCd, epidemiology o. Reliability and validity of the Modified Dental Anxiety Scale (MDAS) in a Turkish population. 2005;33(5):357-62.
• 12. Slade GDJCd, epidemiology o. Derivation and validation of a short‐form oral health impact profile. 1997;25(4):284-90.
• 13. Aktaş B, Ceylan G, Mumcu E, Aksüzek Ö, Ünalan FJJoIUFoD. Protetik Tedavide Yaşam Kalitesi Değerlendirme Yöntemleri Evaluation Methods Of Oral Health Quality Of Life In Prosthetic Dentistry. 2009;43(1-2):59-65.
• 14. Başol Me, Karaağaçlioğlu L, Yilmaz BJTKJoDS. Türkçe Ağız Sağlığı Etki Ölçeğinin Geliştirilmesi-OHIP-14-TR. 2014;20(2).
• 15. McGrath C, Bedi RJCd, epidemiology o. The association between dental anxiety and oral health‐related quality of life in Britain. 2004;32(1):67-72.
• 16. Mumcu G, Inanc N, Ergun T, Ikiz K, Gunes M, Islek U, et al. Oral health related quality of life is affected by disease activity in Behçet's disease. 2006;12(2):145-51.
• 17. Löe HJDc. Periodontal disease: the sixth complication of diabetes mellitus. 1993;16(1):329-34.
• 18. Caltabiano ML, Croker F, Page L, Sklavos A, Spiteri J, Hanrahan L, et al. Dental anxiety in patients attending a student dental clinic. 2018;18:1-8.
• 19. John MT, Koepsell TD, Hujoel P, Miglioretti DL, LeResche L, Micheelis WJCd, et al. Demographic factors, denture status and oral health‐related quality of life. 2004;32(2):125-32.
• 20. McGrath C, Bedi RJBdj. Population based norming of the UK oral health related quality of life measure (OHQoL-UK©). 2002;193(9):521-4.
• 21. Ilgüy D, Ilgüy M, Dinçer S, Bayirli GJJoIMR. Reliability and validity of the Modified Dental Anxiety Scale in Turkish patients. 2005;33(2):252-9.
• 22. Carta MG, Loviselli A, Hardoy MC, Massa S, Cadeddu M, Sardu C, et al. The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. 2004;4:1-5.
• 23. Kang S. Autoimmune thyroiditis, depression, and anxiety. Elsevier Science INC 360 Park Ave South, New York, NY 10010-1710 USA; 2018.
• 24. Azuma N, Iwatani M, Yokoyama Y, Hashimoto N, Tamura M, Hashimoto T, et al. POS1251 Oral Health-Related Quality Of Life In Sjögren’s Syndrome Patients With Unstimulated Whole Salivary Flows≥ 0.1 Ml/Min For Whom No Therapeutic Approaches Are Provided In The Eular Recommendations. BMJ Publishing Group Ltd; 2024.
• 25. Rusthen S, Young A, Herlofson BB, Aqrawi LA, Rykke M, Hove LH, et al. Oral disorders, saliva secretion, and oral health‐related quality of life in patients with primary Sjögren's syndrome. 2017;125(4):265-71.
• 26. Salehi M, Ehsani H, Moosazadeh M, Kashi Z, Fardadamini M, Aryana M, et al. Comparing Oral Health Related Quality of Life Between Patients with Thyroid Disorders and Healthy Individuals. 2022;32(213):114-24.
• 27. de Pinho AMS, Borges CM, de Abreu MHNG, e Ferreira EF, Vargas AMDJIjod. Impact of periodontal disease on the quality of life of diabetics based on different clinical diagnostic criteria. 2012;2012(1):986412.